NCT00012207View on ClinicalTrials.gov

Biological Therapy After Chemotherapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

September 30, 2000

Study Completion Date

July 31, 2010

Conditions
LeukemiaLymphoma
Interventions
BIOLOGICAL

aldesleukin

BIOLOGICAL

therapeutic autologous lymphocytes

DRUG

cyclophosphamide

DRUG

prednisone

DRUG

vincristine sulfate

PROCEDURE

adjuvant therapy

Trial Locations (3)

98195

University of Washington School of Medicine, Seattle

91010-3000

City of Hope Comprehensive Cancer Center, Duarte

98109-1024

Fred Hutchinson Cancer Research Center, Seattle

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Fred Hutchinson Cancer Center

OTHER

NCT00012207 - Biological Therapy After Chemotherapy in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter